Dow Up 1.32% Nasdaq Up 1.60%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
35.03 2.76(8.55%) Oct 23, 4:00PM EDT
Prev Close:32.27
Open:32.70
Bid:34.51 x 500
Ask:39.00 x 100
1y Target Est:43.23
Beta:1.6
Next Earnings Date:30-Oct-14ACOR Earnings announcement
Day's Range:32.57 - 35.44
52wk Range:27.51 - 39.95
Volume:1,131,111
Avg Vol (3m):691,445
Market Cap:1.44B
P/E (ttm):78.37
EPS (ttm):0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORUp 8.55%1.44B
BIIB74.64B
TEVA45.76B

Key Statistics

Forward P/E (1 yr):109.47
P/S (ttm):3.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.18
Quarterly EPS Est (Sep-14) :0.05
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):3.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback